PRODUÇÃO CIENTÍFICA SOBRE GOVERNANÇA CORPORATIVA: ANíLISE DOS ARTIGOS PUBLICADOS EM REVISTAS DE CONTABILIDADE NO BRASIL NO PERÍODO DE 2010 A 2015

This study aims at the investigation of scientific production on the topic "˜Corporate Governance"™ based on articles published in the main brazilian journals of Accounting, from 2010 to 2015. In this context, this is a bibliographical and descriptive study, with predominantly quantitative approach. The sample is composed of 50 articles, wich were collected from journals classified A2 and B1 by the Qualis / Capes. Data were analyzed using descriptive statistics, supplemented by analysis of keywords of articles based on the cloud of words. The main results show that the year 2014 presented 14 published articles (28,00% of the sample); the most prolific authors are Amaral, Correia, De Luca and Ponte; the leading institution in scientific literature on the topic CorporateGovernance in the Accounting area is the University of São Paulo (20,00% of the sample); the brazilian region that produced more articles is the Southeast (50,00% of the sample). After refined the keywords of each article that makes up the sample, it wasfound thatthosewho exceed more in terms of occurrence in thearticles were "˜disclosure"™ and "˜earnings management"™. This study is a current topic and can contribute to researchers, higher education institutions, professionals and other interested parties to better understand the evolution of corporate governance theme in academic journals of Accounting in Brazil.O objetivo deste artigo é investigar a produção cientí­fica sobre o tema "˜governança corporativa"™, com base em artigos publicados em revistas nacionais de contabilidade no perí­odo de 2010 a 2015. Trata-se de pesquisa bibliográfica, de natureza descritiva e com abordagem predominantemente quantitativa. A amostra é composta por 50 artigos coletados nas referidas revistas, selecionadas por serem classificadas de A2 a B1 no Qualis/Capes. A análise dos dados empregou a estatí­stica descritiva, complementada pela análise das palavras-chave dos artigos baseada na elaboração de nuvem de palavras. Os principais resultados da estatí­stica descritiva indicam que o ano de 2014apresentou 14 artigos publicados (28,00% da amostra); os autores mais prolí­ficos são Amaral, Correia, De Luca e Ponte; a instituição com destaque na produção cientí­fica sobre o tema é a Universidade de São Paulo (20,00% da amostra) e a região do Paí­s com produção relevante sobre o tema é a Sudeste (50,00% da amostra). A análise das palavras-chave indicou, entre as mais recorrentes, "˜Gerenciamento de Resultados"™ e "˜Evidenciação"™. Este estudo aborda um tema atual, podendo contribuir para que pesquisadores, instituições de ensino superior, profissionais e demais partes interessadas possam melhor entender a evolução do tema governança corporativa em periódicos acadêmicos de contabilidade no Brasil

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

The International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) COVID-19 dataset is one of the largest international databases of prospectively collected clinical data on people hospitalized with COVID-19. This dataset was compiled during the COVID-19 pandemic by a network of hospitals that collect data using the ISARIC-World Health Organization Clinical Characterization Protocol and data tools. The database includes data from more than 705,000 patients, collected in more than 60 countries and 1,500 centres worldwide. Patient data are available from acute hospital admissions with COVID-19 and outpatient follow-ups. The data include signs and symptoms, pre-existing comorbidities, vital signs, chronic and acute treatments, complications, dates of hospitalization and discharge, mortality, viral strains, vaccination status, and other data. Here, we present the dataset characteristics, explain its architecture and how to gain access, and provide tools to facilitate its use